Tandem Diabetes Care Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
63,138.80
79,524.00
72,418.00
83,447.00
73,033.00
122,611
Depreciation, Depletion & Amortization
3,166.80
4,389.00
4,829.00
5,489.00
6,866.00
5,821
Other Funds
-
50.00
-
-
8,000.00
100,010
Funds from Operations
44,611.40
59,582.00
53,800.00
61,285.00
50,027.00
16,780
Changes in Working Capital
3,145.20
1,796.00
4,964.00
112.00
16,109.00
8,461
Net Operating Cash Flow
47,756.70
61,378.00
58,764.00
61,173.00
66,136.00
8,319
Capital Expenditures
6,009.80
4,579.00
5,838.00
8,930.00
5,718.00
Purchase/Sale of Investments
5,095.30
30,891.00
8,259.00
19,378.00
8,500.00
Net Investing Cash Flow
11,105.10
35,470.00
2,421.00
10,448.00
2,782.00
Issuance/Reduction of Debt, Net
22,478.20
75.00
-
49,994.00
-
Net Financing Cash Flow
166,084.20
3,639.00
68,255.00
52,315.00
32,376.00
Net Change in Cash
107,222.40
93,209.00
11,912.00
1,590.00
30,978.00
Free Cash Flow
51,766.40
65,784.00
64,528.00
70,103.00
71,854.00
Change in Capital Stock
143,606.00
3,664.00
68,255.00
2,321.00
40,376.00

About Tandem Diabetes Care

View Profile
Address
11075 Roselle Street
San Diego California 92121
United States
Employees -
Website http://www.tandemdiabetes.com
Updated 07/08/2019
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M.